These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2384135)

  • 21. Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride.
    Barnes NM; Costall B; Ironside JW; Naylor RJ
    J Pharm Pharmacol; 1988 Sep; 40(9):668. PubMed ID: 2907045
    [No Abstract]   [Full Text] [Related]  

  • 22. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers.
    Pinkus LM; Sarbin NS; Gordon JC; Munson HR
    Eur J Pharmacol; 1990 Apr; 179(1-2):231-5. PubMed ID: 2364986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zacopride and its optical isomers produce stereoselective antagonism of a 2-methylserotonin discriminative stimulus.
    Young R; Glennon RA
    Eur J Pharmacol; 1992 Feb; 212(1):117-9. PubMed ID: 1555633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain.
    Parker RM; Barnes JM; Ge J; Barber PC; Barnes NM
    J Neurol Sci; 1996 Dec; 144(1-2):119-27. PubMed ID: 8994113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
    Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
    Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of [3H]zacopride with 5-HT3 binding sites.
    Pinkus LM; Sarbin NS; Barefoot DS; Gordon JC
    Eur J Pharmacol; 1989 Sep; 168(3):355-62. PubMed ID: 2583241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist effects at putative central 5-HT4 receptors in rat hippocampus by R(+)- and S(-)-zacopride; no evidence for stereo-selectivity.
    Boddeke HW; Kalkman HO
    Neurosci Lett; 1992 Jan; 134(2):261-3. PubMed ID: 1589153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
    Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.
    Gordon JC; Barefoot DS; Sarbin NS; Pinkus LM
    J Pharmacol Exp Ther; 1989 Dec; 251(3):962-8. PubMed ID: 2600824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
    Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1990 Jul; 254(1):350-5. PubMed ID: 2366187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zacopride: anxiolytic profile in rodent and primate models of anxiety.
    Costall B; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ
    J Pharm Pharmacol; 1988 Apr; 40(4):302-5. PubMed ID: 2900320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emetic activity of zacopride in ferrets and its antagonism by pharmacological agents.
    Sancilio LF; Pinkus LM; Jackson CB; Munson HR
    Eur J Pharmacol; 1990 Jun; 181(3):303-6. PubMed ID: 2384137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cells.
    Miquel MC; Emerit MB; Gozlan H; Hamon M
    Biochem Pharmacol; 1991 Sep; 42(7):1453-61. PubMed ID: 1930269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
    Chen JP; van Praag HM; Gardner EL
    Brain Res; 1991 Mar; 543(2):354-7. PubMed ID: 1711914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
    Hewlett WA; Trivedi BL; Zhang ZJ; de Paulis T; Schmidt DE; Lovinger DM; Ansari MS; Ebert MH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):221-31. PubMed ID: 9862774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?
    Andrews N; File SE
    Psychopharmacology (Berl); 1992; 108(3):333-7. PubMed ID: 1523283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.
    Steward LJ; Ge J; Bentley KR; Barber PC; Hope AG; Lambert JJ; Peters JA; Blackburn TP; Barnes NM
    Br J Pharmacol; 1995 Sep; 116(2):1781-8. PubMed ID: 8528560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced anxiolytic effect of zacopride enantiomers in diazepam-withdrawn rats.
    File SE; Andrews N
    Eur J Pharmacol; 1993 Jun; 237(1):127-30. PubMed ID: 8102974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.